Back to the list
Congress: ECR25
Poster Number: C-14727
Type: Poster: EPOS Radiologist (scientific)
Authorblock: A-K. Kaufmann-Bühler1, E. Talakic1, D. Kniepeiss1, J. Kahn1, H. Müller1, F. F. Hohenberg1, M. Fuchsjäger1, H. Schoellnast1, P. Schemmer2; 1Graz/AT, 2Bern/CH
Disclosures:
Ann-Katrin Kaufmann-Bühler: Nothing to disclose
Emina Talakic: Nothing to disclose
Daniela Kniepeiss: Nothing to disclose
Judith Kahn: Nothing to disclose
Helmut Müller: Nothing to disclose
Florian Fritz Hohenberg: Nothing to disclose
Michael Fuchsjäger: Nothing to disclose
Helmut Schoellnast: Nothing to disclose
Peter Schemmer: Nothing to disclose
Keywords: Abdomen, Contrast agents, Liver, MR, MR-Functional imaging, Contrast agent-intravenous, Transplantation
References
  1. Pollok JM, Tinguely P, Berenguer M, et al. Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference. Lancet Gastroenterol Hepatol. 2023;8(1):81-94. doi:10.1016/S2468-1253(22)00268-0
  2. Kok B, Dong V, Karvellas CJ. Graft Dysfunction and Management in Liver Transplantation. Crit Care Clin. 2019;35(1):117-133. doi:10.1016/j.ccc.2018.08.002
  3. Berry PA, Melendez HV, Wendon JA. Postoperative Care of the Liver-Transplant Patient. In: Surgical Intensive Care Medicine. Springer US; 2010:629-638. doi:10.1007/978-0-387-77893-8_53

  4. Girometti R. Post-operative imaging in liver transplantation: State-of-the-art and future perspectives. World J Gastroenterol. 2014;20(20):6180. doi:10.3748/wjg.v20.i20.6180

  5. Poetter-Lang S, Bastati N, Messner A, et al. Quantification of liver function using gadoxetic acid-enhanced MRI. Abdominal Radiology. 2020;45(11):3532-3544. doi:10.1007/s00261-020-02779-x

  6. Bastati N, Beer L, Mandorfer M, et al. Does the Functional Liver Imaging Score Derived from Gadoxetic Acid–enhanced MRI Predict Outcomes in Chronic Liver Disease? Radiology. 2020;294(1):98-107. doi:10.1148/radiol.2019190734

  7. Bastati N, Wibmer A, Tamandl D, et al. Assessment of Orthotopic Liver Transplant Graft Survival on Gadoxetic Acid–Enhanced Magnetic Resonance Imaging Using Qualitative and Quantitative Parameters. Invest Radiol. 2016;51(11):728-734. 
  8. Wei J, Jiang H, Gu D, et al. Radiomics in liver diseases: Current progress and future opportunities. Liver Int. 2020;40(9):2050-2063. doi:10.1111/liv.14555
  9. Verloh N, Haimerl M, Zeman F, et al. Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla. Eur Radiol. 2014;24(5):1013-1019. doi:10.1007/s00330-014-3108-y
  10. Nioche C, Orlhac F, Boughdad S, et al. LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity. Cancer Res. 2018;78(16):4786-4789. doi:10.1158/0008-5472.CAN-18-0125
GALLERY